1. Home
  2. CDW vs MDGL Comparison

CDW vs MDGL Comparison

Compare CDW & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CDW Corporation

CDW

CDW Corporation

N/A

Current Price

$114.54

Market Cap

13.9B

ML Signal

N/A

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

N/A

Current Price

$526.42

Market Cap

11.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDW
MDGL
Founded
1984
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
11.5B
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
CDW
MDGL
Price
$114.54
$526.42
Analyst Decision
Buy
Strong Buy
Analyst Count
8
12
Target Price
$164.88
$674.45
AVG Volume (30 Days)
2.2M
261.7K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.86%
N/A
EPS Growth
1.38
41.32
EPS
1.82
N/A
Revenue
$10,768,600,000.00
$180,133,000.00
Revenue This Year
$4.08
$58.39
Revenue Next Year
$4.01
$48.55
P/E Ratio
$62.85
N/A
Revenue Growth
6.32
N/A
52 Week Low
$97.12
$266.54
52 Week High
$183.91
$615.00

Technical Indicators

Market Signals
Indicator
CDW
MDGL
Relative Strength Index (RSI) 47.94 51.18
Support Level $97.12 $498.59
Resistance Level $125.24 $548.47
Average True Range (ATR) 3.97 19.68
MACD 1.21 -0.42
Stochastic Oscillator 82.14 52.36

Price Performance

Historical Comparison
CDW
MDGL

About CDW CDW Corporation

CDW Corp is a multi-brand provider of information technology (IT) solutions to businesses, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's offerings range from hardware and software products to integrated IT solutions and services, including on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. Its reportable segments are Corporate, Small Business, Public, and Other. The Corporate and Small Business segments serve US private sector business customers, while the Public segment consists of government agencies and education and healthcare institutions in the US. The Corporate segment generates the majority of its revenue in the United States.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: